News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Collins Helen Louise
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
4
| Collins Helen Louise (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 26,000 options to buy
@ $13.32, valued at
$346.3k
|
|
| 02/27/2023 |
4
| Collins Helen Louise (Chief Medical Officer) has filed a Form 4 on Enliven Therapeutics, Inc.|
Txns:
| Granted 287,084 options to buy
@ $2.48, valued at
$712k
|
|
| 02/27/2023 |
3
| Collins Helen Louise (Director) has filed a Form 3 on Enliven Therapeutics, Inc. |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
4
| Collins Helen Louise (EVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 11,583 shares
@ $16.14, valued at
$186.9k
Exercised 22,000 options to buy
@ $0 |
|
| 11/13/2020 |
4
| Collins Helen Louise (EVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 11,039 shares
@ $18, valued at
$198.7k
Exercised 22,000 options to buy
@ $0 |
|
| 08/24/2020 |
4
| Collins Helen Louise (EVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 827 shares
@ $4.69, valued at
$3.9k
|
|
| 03/23/2020 |
4
| Collins Helen Louise (EVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 827 shares
@ $2.3, valued at
$1.9k
|
|
| 02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2020 |
4
| Collins Helen Louise (EVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 5,345 shares
@ $5.13, valued at
$27.4k
|
|
| 09/04/2019 |
4
| Collins Helen Louise (EVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 496 shares
@ $5.43, valued at
$2.7k
|
|
| 08/22/2019 |
4
| Collins Helen Louise (EVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Granted 5,000 shares
@ $0
Granted 20,000 options to buy
@ $5.78, valued at
$115.6k
|
|
| 06/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2019 |
3/A
| Collins Helen Louise (SVP and Chief Medical Officer) has filed a Form 3/A on FIVE PRIME THERAPEUTICS INC |
| 02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2018 |
4
| Collins Helen Louise (SVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 496 shares
@ $14, valued at
$6.9k
|
|
| 06/26/2018 |
4
| Collins Helen Louise (SVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 1,240 shares
@ $17.38, valued at
$21.6k
|
|
| 03/22/2018 |
4
| Collins Helen Louise (SVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 827 shares
@ $16.26, valued at
$13.4k
|
|
| 02/28/2018 |
4
| Collins Helen Louise (SVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 940 shares
@ $31.24, valued at
$29.4k
Granted 7,000 shares
@ $0
Granted 50,000 options to buy
@ $18.69, valued at
$934.5k
|
|
| 02/28/2018 |
3/A
| Collins Helen Louise (SVP and Chief Medical Officer) has filed a Form 3/A on FIVE PRIME THERAPEUTICS INC |
| 02/07/2018 |
4
| Collins Helen Louise (SVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 1,048 shares
@ $18.42, valued at
$19.3k
|
|
| 09/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/22/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|